Insulin release indices: formulas and interpretation
Source:vignettes/articles/insulin-release-indices.Rmd
insulin-release-indices.Rmdinsulin_release() computes eight surrogate indices of
beta-cell insulin secretion from fasting and 75 g oral glucose tolerance
test (OGTT) data. This article gives the exact formula, units and
interpretation of each, and the references they come from.
Units and conversions
The source formulae mix conventional and SI units, so
insulin_release() converts internally before applying each
equation:
| Quantity | Input unit | Converted to | Factor |
|---|---|---|---|
Glucose (G0, G30, G120) |
mmol/L | mg/dL | x 18 |
Insulin (I0, I30, I120) |
pmol/L | microU/mL |
x 0.1667 (that is, / 6) |
sex enters the BIGTT equations as a male indicator (male
= 1, otherwise female), and bmi is in kg/m^2. The
subscripts 0, 30 and 120 denote minutes after the glucose load.
Fasting index
| Index | Formula (converted units) | Reference |
|---|---|---|
Homa_beta |
(20 x I0_uU) / (G0 - 3.5) |
Matthews 1985 |
HOMA-beta estimates steady-state basal beta-cell
function. Higher values mean greater fasting insulin output; markedly
high values often reflect compensatory hypersecretion in the face of
insulin resistance, while low values suggest beta-cell insufficiency. It
is undefined as G0 approaches 3.5 mmol/L.
OGTT indices
| Index | Formula (converted units) | Reference |
|---|---|---|
Cir |
(100 x I30_uU) / (G30_mg x (G30_mg - 70)) |
Sluiter 1976 |
Stumvoll |
1283 + 1.829 x I30 - 138.7 x G30 + 3.772 x I0 (pmol/L,
mmol/L) |
Stumvoll 2000 |
Xinsdg30 |
((I30 - I0)_uU) / ((G30 - G0)_mg) |
insulinogenic index |
Xinsg30 |
((I30 - I0)_uU) / G30 (mmol/L) |
insulinogenic index |
Di |
Xinsg30 x 1000 / (sqrt(G0_mg x I0_uU) x meanG_mg x meanI_uU) |
Madsen 2024 (see note) |
Bigtt_air |
exp(8.20 + 0.00178 I0 + 0.00168 I30 - 0.000383 I120 - 0.314 G0 - 0.109 G30 + 0.0781 G120 + 0.180 sex + 0.032 bmi) |
Hansen 2007 |
Dibig |
Bigtt_air x exp(4.90 - 0.00402 I0 - 0.000556 I30 - 0.00127 I120 - 0.152 G0 - 0.00871 G30 - 0.0373 G120 - 0.145 sex - 0.0376 bmi) |
Madsen 2024 |
where meanG and meanI are the row means of
glucose and insulin across 0, 30 and 120 min.
Interpretation.
-
Cir(corrected insulin response) and the insulinogenic indices (Xinsdg30,Xinsg30) capture the early-phase insulin response to glucose; higher is greater early secretion. -
StumvollandBigtt_airestimate first-phase / acute insulin release; higher means a larger burst. -
DiandDibigare disposition indices: insulin secretion scaled by insulin sensitivity. Because a healthy beta cell secretes more when the body is more resistant, the disposition index is the key measure of whether secretion is adequate for the prevailing sensitivity. Lower values indicate beta-cell failure to compensate and are a strong predictor of progression to type 2 diabetes.
Note on the Di formula
The Di equation is transcribed exactly as
reported in the Madsen (2024) index table: the square root
covers only G0_mg x I0_uU, with the mean terms outside the
root and a numerator of 1000. This is not identical to the canonical
Matsuda-based disposition index (a single square root over all four
terms, numerator 10000). We keep the as-reported form so results
reproduce the source exactly; if you need the Matsuda-standard
disposition index, compute it separately.
Worked example
data(example_data)
res <- insulin_release(example_data, category = c("fasting", "ogtt"))
round(head(res[, c("Homa_beta", "Cir", "Stumvoll", "Xinsg30",
"Di", "Bigtt_air", "Dibig")], 5), 3)
#> Homa_beta Cir Stumvoll Xinsg30 Di Bigtt_air Dibig
#> 1 85.085 0.386 850.569 4.512 0.043 1161.789 13100.08
#> 2 84.846 0.205 542.216 2.253 0.045 1650.537 16881.84
#> 3 267.638 0.849 1462.166 9.032 0.049 3477.854 24216.88
#> 4 133.546 0.679 1196.181 6.875 0.058 2609.218 24179.56
#> 5 64.021 0.259 587.807 3.048 0.071 1734.967 17734.61References
- Madsen AL, et al. (2024). Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology. Nature Metabolism. https://doi.org/10.1038/s42255-024-01140-6
- Matthews DR, et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. https://doi.org/10.1007/BF00280883
- Sluiter WJ, et al. (1976). Glucose tolerance and insulin release, a mathematical approach. Diabetes, 25(4). https://doi.org/10.2337/diab.25.4.241
- Stumvoll M, et al. (2000). Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care, 23(3), 295-301. https://doi.org/10.2337/diacare.23.3.295
- Matsuda M, DeFronzo RA (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care, 22(9), 1462-1470. https://doi.org/10.2337/diacare.22.9.1462
- Hansen T, et al. (2007). The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care, 30(2), 257-262. https://doi.org/10.2337/dc06-1240